These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10614851)

  • 1. Development of ventricular fibrillations with different characteristics in the local electrocardiogram: large and small amplitude of activation, and its implication for implantable cardioverter defibrillator treatment.
    Chinushi M; Washizuka T; Kasai H; Ohhira K; Satoh M; Aizawa Y
    Jpn Circ J; 1999 Dec; 63(12):1007-10. PubMed ID: 10614851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventricular fibrillation with small amplitude of activation and its implications for implantable cardioverter defibrillator treatment.
    Chinushi M; Kasai H; Tagawa M; Washizuka T; Aizawa Y
    Jpn Heart J; 1999 Jan; 40(1):87-90. PubMed ID: 10370401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sinus rhythm R-wave amplitude as a predictor of ventricular fibrillation undersensing in patients with implantable cardioverter-defibrillator.
    Ruetz LL; Koehler JL; Brown ML; Jackson TE; Belk P; Swerdlow CD
    Heart Rhythm; 2015 Dec; 12(12):2411-8. PubMed ID: 26272520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dispersion of ventricular repolarization after an implantable defibrillator shock predicts induction of ventricular fibrillation as well as unsuccessful defibrillation.
    Moubarak JB; Karasik PE; Fletcher RD; Franz MR
    J Am Coll Cardiol; 2000 Feb; 35(2):422-7. PubMed ID: 10676690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease in amplitude of intracardiac ventricular electrogram and inappropriate therapy in patients with an implantable cardioverter defibrillator.
    Watanabe H; Chinushi M; Izumi D; Sato A; Okada S; Okamura K; Komura S; Hosaka Y; Furushima H; Washizuka T; Aizawa Y
    Int Heart J; 2006 May; 47(3):363-70. PubMed ID: 16823242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Train tracks" and "step ladders" on implantable cardioverter defibrillator interval plot in a patient with dual tachycardia: Putting the dots together.
    Saini A; Ellenbogen KA; Tan A; Kaszala K; Huizar JF
    Pacing Clin Electrophysiol; 2017 Nov; 40(11):1298-1301. PubMed ID: 28901551
    [No Abstract]   [Full Text] [Related]  

  • 8. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry.
    Ellenbogen KA; Koneru JN; Sharma PS; Deshpande S; Wan C; Szymkiewicz SJ
    JACC Clin Electrophysiol; 2017 Mar; 3(3):243-250. PubMed ID: 29759518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of abortive shock capability with electrogram storage in cardioverter-defibrillator devices.
    Hurwitz JL; Hook BG; Flores BT; Marchlinski FE
    J Am Coll Cardiol; 1993 Mar; 21(4):895-900. PubMed ID: 8450157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Undersensing during ventricular tachyarrhythmias in a third-generation implantable cardioverter defibrillator: diagnosis using stored electrograms and correction with programming.
    Mann DE; Kelly PA; Damle RS; Reiter MJ
    Pacing Clin Electrophysiol; 1994 Sep; 17(9):1525-30. PubMed ID: 7991424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Programming of implantable cardioverter-defibrillators on the basis of the upper limit of vulnerability.
    Swerdlow CD; Peter CT; Kass RM; Gang ES; Mandel WJ; Hwang C; Martin DJ; Chen PS
    Circulation; 1997 Mar; 95(6):1497-504. PubMed ID: 9118518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%.
    Grimm W; Hoffmann J Jü; Müller HH; Maisch B
    J Am Coll Cardiol; 2002 Mar; 39(5):780-7. PubMed ID: 11869841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mean ventricular fibrillation cycle length: a potentially useful parameter for programming implantable cardioverter defibrillators.
    Li H; Easley A; Windle J; Samoil D; Barrington W
    Pacing Clin Electrophysiol; 1998 Sep; 21(9):1789-94. PubMed ID: 9744444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and limitations of treatment of ventricular fibrillation/ventricular tachycardia storm by subcutaneous implantable cardioverter defibrillator.
    Nagra B; Awan MU; Miriyala V; Kantharia BK
    Int J Cardiol; 2016 Nov; 222():978-979. PubMed ID: 27529389
    [No Abstract]   [Full Text] [Related]  

  • 16. T-peak to T-end interval for prediction of ventricular tachyarrhythmia and mortality in a primary prevention population with systolic cardiomyopathy.
    Rosenthal TM; Stahls PF; Abi Samra FM; Bernard ML; Khatib S; Polin GM; Xue JQ; Morin DP
    Heart Rhythm; 2015 Aug; 12(8):1789-97. PubMed ID: 25998895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracardiac J-point elevation before the onset of polymorphic ventricular tachycardia and ventricular fibrillation in patients with an implantable cardioverter-defibrillator.
    Tereshchenko LG; McCabe A; Han L; Sur S; Huang T; Marine JE; Cheng A; Spragg DD; Sinha S; Calkins H; Stein K; Tomaselli GF; Berger RD
    Heart Rhythm; 2012 Oct; 9(10):1594-602. PubMed ID: 22750217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
    Singh JP; Hall WJ; McNitt S; Wang H; Daubert JP; Zareba W; Ruskin JN; Moss AJ;
    J Am Coll Cardiol; 2005 Nov; 46(9):1712-20. PubMed ID: 16256874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spurious redetection of sinus rhythm by an implantable cardioverter defibrillator during spontaneous ventricular fibrillation.
    Otto L; Mann DE; Kelly PA; Reiter MJ
    Pacing Clin Electrophysiol; 1999 Oct; 22(10):1550-2. PubMed ID: 10588160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined third-generation implantable cardioverter defibrillator with permanent unipolar pacemakers: preliminary observations.
    Haffajee C; Casavant D; Desai P; Moon R; Voukydis P; Pacetti P
    Pacing Clin Electrophysiol; 1996 Feb; 19(2):136-42. PubMed ID: 8834682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.